Claudin-18 isoform 2-specific CAR T-cell therapy (satri-cel) versus treatment of physician's choice for previously treated advanced gastric or gastro-oesophageal junction cancer (CT041-ST-01): a randomised, open-label, phase 2 trial
Changsong Qi(Peking University), Chang Liu(Ministry of Education), Zhi Peng(Peking University), Yanqiao Zhang(Harbin Medical University), Jia Wei(Nanjing Drum Tower Hospital), Wensheng Qiu(Qingdao University), Xiaotian Zhang(Peking University), Hongming Pan(Sir Run Run Shaw Hospital), Zuoxing Niu(Shandong First Medical University), Meng Qiu(Sichuan University), Yanru Qin(First Affiliated Hospital of Zhengzhou University), Weijia Fang(First Affiliated Hospital Zhejiang University), Feng Ye(First Affiliated Hospital of Xiamen University), Ning Li(Zhengzhou University), Tianshu Liu(Sun Yat-sen University), Anwen Liu(Nanchang University), Xizhi Zhang(Peking University), Changlu Hu(Anhui Provincial Hospital), Jun Zhang(Ruijin Hospital), Jiuwei Cui(Jilin University), Xiaoyan Lin(Fujian Medical University), Shubin Wang(Peking University Shenzhen Hospital), Jian Zhang(Ruijin Hospital), Tong-Yu Lin(University of Electronic Science and Technology of China), Xiujuan Qu(First Hospital of China Medical University), Xianglin Yuan(Tongji Hospital), Jifang Gong(Peking University), Jian Li(Peking University), Wanwan Gao, Li Gai, Yumeng Wang, Daijing Yuan, Zonghai Li, Lin Shen(Peking University)
Cited by 98Open Access
Abstract
Related Papers
No related papers found
Powered by citation graph analysis